Rare diseases
Investigational molecules
Locations
453 conditions with trials, the busiest first
1 389 trials across Europe, recruiting first
Study on Masupirdine for Treating Agitation in Alzheimer's Dementia Patients
CroatiaStudy on the Safety and Effectiveness of AMX0035 (Phenylbutyrate and Ursodoxicoltaurine) for Adults with Amyotrophic Lateral Sclerosis (ALS)
BelgiumStudy on Asundexian for Preventing Ischemic Stroke in Adults After a Stroke or High-Risk Mini-Stroke
AustriaStudy Comparing CT-P53 and Ocrelizumab for Patients with Relapsing-Remitting Multiple Sclerosis
BulgariaStudy on Botulinum Toxin Type A for Preventing Episodic Migraine in Adults
CzechiaStudy on Botulinum Toxin Type A for Preventing Chronic Migraine in Adults
CzechiaStudy on the Long-Term Safety and Effectiveness of Minzasolmin and Iodine Ioflupane (123I) in Patients with Parkinson's Disease
FranceStudy on the Effectiveness and Safety of NT 201 Injections for Adults with Chronic Neuropathic Pain from Postherpetic Neuralgia or Nerve Injury
BulgariaStudy on the Effects of Tasipimidine for Patients with Insomnia Disorder
FinlandStudy on PRAX-628 for Adults with Focal Epilepsy Taking 1 to 3 Anti-Seizure Medications
ItalyStudy on Basimglurant for Treating Pain in Patients with Trigeminal Neuralgia
DenmarkStudy on Ublituximab for Patients with Relapsing Multiple Sclerosis
CroatiaThe therapies tested most often in Nervous system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
